Executive Summary

In the first quarter of 2026, Switzerland recorded a significant decline in foreign trade. Exports fell by 4.2 percent seasonally adjusted compared to Q4 2025, reaching the lowest level since Q3 2021. Imports fell by 4.7 percent. The chemicals-pharmaceuticals sector was largely responsible for both developments. Despite the declines, Switzerland recorded a positive trade balance of 11.1 billion francs.

Persons

  • Federal Customs and Border Security Office BAZG (Source)

Topics

  • Foreign trade statistics
  • Export development
  • Chemicals-pharmaceuticals sector
  • Trade balance

Clarus Lead

The export crisis marks a trend reversal with significant implications for the Swiss economy. The decline to the lowest level in five years signals structural weaknesses, particularly in the chemicals-pharmaceuticals sector, which is considered a cornerstone of Swiss export economy. The parallel import contraction points to dampened domestic demand – an indicator of economic uncertainty that goes beyond mere seasonal effects.

Detailed Summary

The foreign trade statistics for the first quarter of 2026 document a remarkable tightening of economic dynamics. The export decline of 4.2 percent should not be viewed in isolation, but rather as part of an ongoing negative trend that began in Q4 2025. With the drop to Q3 2021 levels, Switzerland loses five quarters of recovery momentum.

Imports contracted even more sharply than exports at 4.7 percent. This suggests that not only external demand weakness, but also internal purchasing power dampening is at work. The chemicals-pharmaceuticals sector contributed significantly to developments in both directions – a critical signal, as this sector accounts for approximately one-third of Swiss exports.

On the positive side is the trade balance of 11.1 billion francs, which maintains a robust structural export surplus. This shows that despite volume declines, Switzerland maintains its value-added position – possibly through price effects or shifts in product mix towards higher-value goods.

Key Findings

  • Swiss exports fall by 4.2% and reach lowest level since Q3 2021
  • Imports contract by 4.7%; both trends seasonally adjusted
  • Chemicals-pharmaceuticals sector is main driver of negative development
  • Trade balance remains positive at 11.1 billion francs

Critical Questions

  1. Evidence: Are the 4.2% and 4.7% declines seasonally adjusted or nominal? What base effects could influence the comparison to Q4 2025?

  2. Source Validity: Is the statistic based on customs declarations or goods flows? How timely is the data captured?

  3. Causality: Is the chemicals-pharmaceuticals decline demand-driven (global economy) or supply-driven (production failures, supply chain problems)?

  4. Conflicts of Interest: What economic policy measures are being discussed by the federal government or industry associations in response? Is there an incentive to dramatize the figures?

  5. Alternatives: Could relocation effects (production abroad) or price deflation explain the volume decline, rather than actual demand shortfall?

  6. Feasibility: What measures to promote exports are realistic if the decline in the pharmaceutical sector is structural?

  7. Risks: Does the decline risk intensify in Q2 2026, or does the trend stabilize?

Source Directory

Primary Source: First Quarter 2026: Exports Fall to Lowest Level Since Third Quarter 2021 – Federal Customs and Border Security Office BAZG, 21.04.2026

Verification Status: ✓ 21.04.2026

This text was created with the support of an AI model. Editorial Responsibility: clarus.news | Fact-Check: 21.04.2026